This document is an excerpt from the EUR-Lex website
Document 62015TA0355
Case T-355/15: Judgment of the General Court of 30 September 2016 — Alpex Pharma v EUIPO — Astex Pharmaceuticals (ASTEX) (EU trade mark — Opposition proceedings — Application for EU word mark ASTEX — Earlier EU word mark ALPEX — No genuine use of the earlier mark — Article 42(2) of Regulation (EC) No 207/2009 — Article 75 of Regulation No 207/2009 — Article 76(1) of Regulation No 207/2009)
Case T-355/15: Judgment of the General Court of 30 September 2016 — Alpex Pharma v EUIPO — Astex Pharmaceuticals (ASTEX) (EU trade mark — Opposition proceedings — Application for EU word mark ASTEX — Earlier EU word mark ALPEX — No genuine use of the earlier mark — Article 42(2) of Regulation (EC) No 207/2009 — Article 75 of Regulation No 207/2009 — Article 76(1) of Regulation No 207/2009)
Case T-355/15: Judgment of the General Court of 30 September 2016 — Alpex Pharma v EUIPO — Astex Pharmaceuticals (ASTEX) (EU trade mark — Opposition proceedings — Application for EU word mark ASTEX — Earlier EU word mark ALPEX — No genuine use of the earlier mark — Article 42(2) of Regulation (EC) No 207/2009 — Article 75 of Regulation No 207/2009 — Article 76(1) of Regulation No 207/2009)
IO C 419, 14.11.2016, p. 40–40
(BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
|
14.11.2016 |
EN |
Official Journal of the European Union |
C 419/40 |
Judgment of the General Court of 30 September 2016 — Alpex Pharma v EUIPO — Astex Pharmaceuticals (ASTEX)
(Case T-355/15) (1)
((EU trade mark - Opposition proceedings - Application for EU word mark ASTEX - Earlier EU word mark ALPEX - No genuine use of the earlier mark - Article 42(2) of Regulation (EC) No 207/2009 - Article 75 of Regulation No 207/2009 - Article 76(1) of Regulation No 207/2009))
(2016/C 419/51)
Language of the case: English
Parties
Applicant: Alpex Pharma SA (Mezzovico-Vira, Switzerland) (represented by: C. Bacchini, M. Mazzitelli and E. Rondinelli, lawyers)
Defendant: European Union Intellectual Property Office (represented by: M. Rajh, acting as Agent)
Other party to the proceedings before the Board of Appeal of EUIPO: Astex Pharmaceuticals, Inc. (Plesanton, United States)
Re:
Action brought against the decision of the Second Board of Appeal of EUIPO of 28 April 2015 (Case R 593/2014-2), relating to opposition proceedings between Alpex Pharma and Astex Pharmaceuticals.
Operative part of the judgment
The Court:
|
1. |
Dismisses the action; |
|
2. |
Orders Alpex Pharma, SA, to pay the costs. |